Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: A Randomised, double-blind, multicentre, phase 3 trial - Ascierto, P A; Del Vecchio, M; Robert, C (Lancet Oncol, 2017)
et al.